Regulus Therapeutics (NASDAQ:RGLS)

CAPS Rating: 2 out of 5

Recs

1
Player Avatar OklaBoston (66.45) Submitted: 11/12/2013 5:05:44 PM : Outperform Start Price: $6.20 RGLS Score: +67.59

Takeover candidate in which All-Stars have recently ended red thumbs. 70% insider and 4.6 Quick Ratio indicates a takeover is not a necessity here.

Featured Broker Partners


Advertisement